13F

Stock

Crispr Therapeutics Ag

CRSP · held by 6 managers

Reported value

$5.28M

Holders

6

+0 new · −0 exited

Holders’ est. mark

−$998.6K

Price effect on 4 books still in the name

Largest holder

$4.02M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC102.1K$4.02M−$777.7KCut−$2.08M
Marex Group plc24K$943.3K−$170.1KCut−$105.7K
Norris Financial Group, LLC6.56K$258.4K−$50KCut−$228.1K
Evelyn Partners Investment Management LLP1.3K$51.2KHeld
Medallion Wealth Advisors, LLC124$4.88KHeld
DANSKE BANK A/S100$3.94K−$762Cut−$71.2K

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.